Home
Scholarly Works
Efficacy and safety of edoxaban in clinically...
Conference

Efficacy and safety of edoxaban in clinically relevant subgroups: results from the Hokusai VTE Cancer randomized trial

Authors

Mulder FI; van Es N; Kraaijpoel N; Di Nisio M; Carrier M; Garcia D; Grosso M; Kakkar AK; Mercuri MF; Middeldorp S

Volume

164

Publisher

Elsevier

Publication Date

April 1, 2018

DOI

10.1016/j.thromres.2018.02.035

Conference proceedings

Thrombosis Research

ISSN

0049-3848

Contact the Experts team